Peroxisomes: Adaptive Changes


Immunogold Labelling Smooth Endoplasmic Reticulum Peroxisome Biogenesis Peroxisomal Enzyme Hypolipidemic Drug 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Baumgart E, Stegmeier K, Schmidt F, and Fahimi HD (1987) Proliferation of peroxisomes in pericentral hepatocytes of rat liver after administration of a new hypocholesterolemic agent (BM 15766). Lab Invest 56: 55Google Scholar
  2. Beier K, and Fahimi HD (1992) Environmental pollution by common chemicals and peroxisome proliferation: efficient detection by cytochemistry and automatic image analysis. Progr Histochem Cytochem 25: 150Google Scholar
  3. Bellu A, Komori M, Van der Klei I, Kiel J, and Veenhuis M (2001) Peroxisome biogenesis and selective degradation converge at Pex14p. J Biol Chem 276: 44570CrossRefPubMedGoogle Scholar
  4. Chang C, South S, Warren D, Jones J, and Moser A (1999) Metabolic control of peroxisome abundance. J Cell Sci 112: 1579PubMedGoogle Scholar
  5. Erdmann R, and Blobel G (1995) Giant peroxisomes in oleic acid-induced Saccharomyces cerevisiae lacking the peroxisomal membrane protein Pmp27p. J Cell Biol 135: 111CrossRefGoogle Scholar
  6. Green S, and Wahli W (1994) Peroxisome proliferator-activated receptors — finding the orphan a home. Mol Cell Endocrinol 100: 149CrossRefPubMedGoogle Scholar
  7. Lindauer M, Beier K, Völkl A, and Fahimi HD (1994) Zonal heterogeneity of peroxisomal enzymes in rat liver: differential induction by three divergent hypolipidemic drugs. Hepatology 20: 475CrossRefPubMedGoogle Scholar
  8. Moody D, and Reddy J (1976) Morphometric analysis of the ultrastructural changes in rat liver induced by the peroxisome proliferator SaH 42–348. J Cell Bio 71: 768CrossRefGoogle Scholar

Copyright information

© Springer-Verlag/Wien 2005

Personalised recommendations